Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginTimes Interest Earned

Cellectis (CLLS) Equity Average (2016 - 2025)

Cellectis has reported Equity Average over the past 11 years, most recently at $103.5 million for Q4 2025.

  • Quarterly results put Equity Average at $103.5 million for Q4 2025, down 4.08% from a year ago — trailing twelve months through Dec 2025 was $103.5 million (down 4.08% YoY), and the annual figure for FY2025 was $103.5 million, down 4.08%.
  • Equity Average for Q4 2025 was $103.5 million at Cellectis, down from $107.9 million in the prior quarter.
  • Over the last five years, Equity Average for CLLS hit a ceiling of $272.7 million in Q4 2021 and a floor of $80.4 million in Q4 2023.
  • Median Equity Average over the past 5 years was $107.9 million (2024), compared with a mean of $134.7 million.
  • Biggest five-year swings in Equity Average: plummeted 55.63% in 2023 and later skyrocketed 34.14% in 2024.
  • Cellectis' Equity Average stood at $272.7 million in 2021, then plummeted by 33.54% to $181.2 million in 2022, then plummeted by 55.63% to $80.4 million in 2023, then surged by 34.14% to $107.9 million in 2024, then fell by 4.08% to $103.5 million in 2025.
  • The last three reported values for Equity Average were $103.5 million (Q4 2025), $107.9 million (Q4 2024), and $80.4 million (Q4 2023) per Business Quant data.